Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Stock, Kristin ^a   Estrada, Marta F ^b,c   Vidic, Suzana ^d,e,f   Gjerde, Kjersti ^d,e   Rudisch, Albin ^g   Santo, Vítor E ^b,c   Barbier, Michaël ^d   Blom, Sami ⁱ   Arundkar, Sharath C ^j   Selvam, Irwin ^g   Osswald, Annika ^g,k   Stein, Yan ^j   Gruenewald, Sylvia ^a   Brito, Catarina ^b,c   Van Weerden, Wytske ^e   Rotter, Varda ^j   Boghaert, Erwin ^h   Oren, Moshe ^j   Sommergruber, Wolfgang ^g   Chong, Yolanda ^d   De Hoogt, Ronald ^d   Graeser, Ralph ^l   more..

^a BAYER PHARMA AG   (Germany)

^b INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

^c INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^d JANSSEN RESEARCH FOUNDATION   (Belgium)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF PRIMORSKA   (Slovenia)

^g BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^h ABBVIE INC   (United States)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

^j WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^k MEDICAL UNIVERSITY OF VIENNA   (Austria)

^l BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COCULTURE; COMPARATIVE STUDY; CYTOLOGY; HUMAN; MCF-7 CELL LINE; MULTICELLULAR SPHEROID; PROCEDURES; STROMA CELL; THREE DIMENSIONAL IMAGING; TUMOR CELL LINE;

CELL LINE, TUMOR; COCULTURE TECHNIQUES; HUMANS; IMAGING, THREE-DIMENSIONAL; MCF-7 CELLS; SPHEROIDS, CELLULAR; STROMAL CELLS;

EID: 84976897214     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28951     Document Type: Article

References (52)

1. Scannell, J. W., Blanckley, A., Boldon, H., Warrington, B. Diagnosing the decline in pharmaceutical R&D efficiency. Nature reviews. Drug discovery 11, 191-200, doi: 10.1038/nrd3681 (2012).
2. Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., Rosenthal, J. Clinical development success rates for investigational drugs. Nature biotechnology 32, 40-51, doi: 10.1038/nbt.2786 (2014).
3. Arrowsmith, J. Trial watch: phase III and submission failures: 2007-2010. Nature reviews. Drug discovery 10, 87, doi: 10.1038/nrd3375 (2011).
4. Goodbye, flat biology? Nature 424, 861, doi: 10.1038/424861b (2003).
5. Hickman, J. A. et al. Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex vivo. Biotechnology journal 9, 1115-1128, doi: 10.1002/biot.201300492 (2014).
6. Herrera, V. A., Zeindl-Eberhart, E., Jung, A., Huber, R. M., Bergner, A. The dual PI3K/mTOR inhibitor BEZ235 is effective in lung cancer cell lines. Anticancer research 31, 849-854 (2011).
7. Webber, M. M. et al. A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia. Carcinogenesis 20, 1185-1192 (1999).
8. Madar, S. et al. Modulated expression of WFDC1 during carcinogenesis and cellular senescence. Carcinogenesis 30, 20-27, doi: 10.1093/carcin/bgn232 (2009).
9. Prost-Squarcioni, C., Fraitag, S., Heller, M., Boehm, N. [Functional histology of dermis]. Annales de dermatologie et de venereologie 135, 1S5-20, doi: 10.1016/S0151-9638(08)70206-0 (2008).
10. Conklin, M. W., Keely, P. J. Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers. Cell adhesion & migration 6, 249-260, doi: 10.4161/cam.20567 (2012).
11. Estrada, M. F. et al. Modelling the tumour microenvironment in long-term microencapsulated 3D co-cultures recapitulates phenotypic features of disease progression. Biomaterials epub before print, doi: http://dx.doi.org/10.1016/j.biomaterials.2015.11.030.
12. Rudisch, A. et al. High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFkappaB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts. PloS one 10, e0124283, doi: 10.1371/journal.pone.0124283 (2015).
13. Rudnick, J. A. et al. Functional heterogeneity of breast fibroblasts is defined by a prostaglandin secretory phenotype that promotes expansion of cancer-stem like cells. PloS one 6, e24605, doi: 10.1371/journal.pone.0024605 (2011).
14. Albrengues, J. et al. LIF mediates proinvasive activation of stromal fibroblasts in cancer. Cell Rep 7, 1664-1678, doi: 10.1016/j. celrep.2014.04.036 (2014).
15. Petersen, O. W., Ronnov-Jessen, L., Howlett, A. R., Bissell, M. J. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proceedings of the National Academy of Sciences of the United States of America 89, 9064-9068 (1992).
16. Lu, P., Weaver, V. M., Werb, Z. The extracellular matrix: a dynamic niche in cancer progression. The Journal of cell biology 196, 395-406, doi: 10.1083/jcb.201102147 (2012).
17. Bohari, S. P., Hukins, D. W., Grover, L. M. Effect of calcium alginate concentration on viability and proliferation of encapsulated fibroblasts. Biomed Mater Eng 21, 159-170, doi: 10.3233/BME-2011-0665 (2011).
18. Haubeiss, S. et al. Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Molecular cancer 9, 168, doi: 10.1186/1476-4598-9-168 (2010).
19. Wenzel, C. et al. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions. Experimental cell research 323, 131-143, doi: 10.1016/j.yexcr.2014.01.017 (2014).
20. Santo, V. E. et al. Adaptable stirred-tank culture strategies for large scale production of spheroid-based tumor cell models. J. Biotechnol in revision.
21. Artym, V. V., Matsumoto, K. Imaging cells in three-dimensional collagen matrix. Current protocols in cell biology/editorial board, Juan S. Bonifacino . [et al.] Chapter 10, Unit 10 18 11-20, doi: 10.1002/0471143030.cb1018s48 (2010).
22. Schneider, C. A., Rasband, W. S., Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nature methods 9, 671-675 (2012).
23. Barbier, M. et al. Ellipsoid segmentation model for analyzing light attenuated 3D confocal image stacks of fluorescent multi-cellular spheroids. PloS one in revision.
24. Pinto, M. P., Jacobsen, B. M., Horwitz, K. B. An immunohistochemical method to study breast cancer cell subpopulations and their growth regulation by hormones in three-dimensional cultures. Frontiers in endocrinology 2, 15, doi: 10.3389/fendo.2011.00015 (2011).
25. Amann, A. et al. Development of an innovative 3D cell culture system to study tumour-stroma interactions in non-small cell lung cancer cells. PloS one 9, e92511, doi: 10.1371/journal.pone.0092511 (2014).
26. Provenzano, P. P. et al. Collagen density promotes mammary tumor initiation and progression. BMC medicine 6, 11, doi: 10.1186/1741-7015-6-11 (2008).
27. Sasser, A. K. et al. Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 21, 3763-3770, doi: 10.1096/fj.07-8832com (2007).
28. Su, G., Sung, K. E., Beebe, D. J., Friedl, A. Functional screen of paracrine signals in breast carcinoma fibroblasts. PloS one 7, e46685, doi: 10.1371/journal.pone.0046685 (2012).
29. Krause, S., Maffini, M. V., Soto, A. M., Sonnenschein, C. The microenvironment determines the breast cancer cells' phenotype: organization of MCF7 cells in 3D cultures. BMC cancer 10, 263, doi: 10.1186/1471-2407-10-263 (2010).
30. Vukicevic, S. et al. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Experimental cell research 202, 1-8 (1992).
31. Wakeling, A. E., Dukes, M., Bowler, J. A potent specific pure antiestrogen with clinical potential. Cancer research 51, 3867-3873 (1991).
32. Tran, C. et al. Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science 324, 787-790, doi: 10.1126/science.1168175 (2009).
33. Montero, A., Fossella, F., Hortobagyi, G., Valero, V. Docetaxel for treatment of solid tumours: a systematic review of clinical data. The Lancet. Oncology 6, 229-239, doi: 10.1016/S1470-2045(05)70094-2 (2005).
34. Martinez-Outschoorn, U. E. et al. Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells. Cancer Biol Ther 12, 924-938, doi: 10.4161/cbt.12.10.17780 (2011).
35. Harma, V. et al. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PloS one 5, e10431, doi: 10.1371/journal.pone.0010431 (2010).
36. Folkman, J., Hochberg, M. Self-regulation of growth in three dimensions. The Journal of experimental medicine 138, 745-753 (1973).
37. Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D., Takayama, S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. Journal of controlled release: official journal of the Controlled Release Society 164, 192-204, doi: 10.1016/j.jconrel.2012.04.045 (2012).
38. Grimes, D. R., Kelly, C., Bloch, K., Partridge, M. A method for estimating the oxygen consumption rate in multicellular tumour spheroids. Journal of the Royal Society, Interface/the Royal Society 11, 20131124, doi: 10.1098/rsif.2013.1124 (2014).
39. Boyle, R. G., Travers, S. Hypoxia: targeting the tumour. Anti-cancer agents in medicinal chemistry 6, 281-286 (2006).
40. Kerr, D. J., Wheldon, T. E., Kerr, A. M., Freshney, R. I., Kaye, S. B. The effect of adriamycin and 4?-deoxydoxorubicin on cell survival of human lung tumour cells grown in monolayer and as spheroids. British journal of cancer 54, 423-429 (1986).
41. Kobayashi, H. et al. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proceedings of the National Academy of Sciences of the United States of America 90, 3294-3298 (1993).
42. Frankel, A., Buckman, R., Kerbel, R. S. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Cancer research 57, 2388-2393 (1997).
43. Celli, J. P. et al. An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models. Scientific reports 4, 3751, doi: 10.1038/srep03751 (2014).
44. Kyle, A. H., Huxham, L. A., Yeoman, D. M., Minchinton, A. I. Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors. Clinical cancer research: an official journal of the American Association for Cancer Research 13, 2804-2810, doi: 10.1158/1078-0432.CCR-06-1941 (2007).
45. Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603-607, doi: 10.1038/nature11003 (2012).
46. Loessner, D. et al. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 31, 8494-8506, doi: 10.1016/j.biomaterials.2010.07.064 (2010).
47. Prestwich, G. D. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery. Accounts of chemical research 41, 139-148, doi: 10.1021/ar7000827 (2008).
48. Rampias, T., Favicchio, R., Stebbing, J., Giamas, G. Targeting tumor-stroma crosstalk: the example of the NT157 inhibitor. Oncogene, doi: 10.1038/onc.2015.392 (2015).
49. Straussman, R. et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487, 500-504, doi: 10.1038/nature11183 (2012).
50. Linde, N., Gutschalk, C. M., Hoffmann, C., Yilmaz, D., Mueller, M. M. Integrating macrophages into organotypic co-cultures: a 3D in vitro model to study tumor-associated macrophages. PloS one 7, e40058, doi: 10.1371/journal.pone.0040058 (2012).
51. Miller, J. S. et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nature materials 11, 768-774, doi: 10.1038/nmat3357 (2012).
52. Ghajar, C. M. et al. The perivascular niche regulates breast tumour dormancy. Nature cell biology 15, 807-817, doi: 10.1038/ncb2767 (2013).